US$ 22.10
glp 1 migraine Could GLP-1s prevent migraine? A new study of 22,000 chronic patients suggests...maybe. Over 12 months, GLP-1 users vs topiramate users had: >10% fewer ED visits >14% fewer hospitalizations >48% less likely GLP1 Drugs Might Ease Chronic
Description
This unique formula supports appetite regulation, glucose control, and sustained energy levels, addressing core metabolic and digestive health challenges
Flow Wellness does not claim affiliation with or endorsement by Novo Nordisk or Eli Lilly.

This launch will help empower people to take better control of their metabolic health

Role of funding source: The funders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report
Saha B et al
